FDAMakary’s “Blind Spots” Offers Big Ideas — But Can He Deliver as FDA Commissioner?Suzanne B. Robotti
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung ProblemsKatie Rowley
MedShadow ArticlesFrom Ashwagandha to St. John’s Wort: The Risks Behind 5 Trending SupplementsJessie Sebor
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Remicade and the Onset of New Autoimmune Diseases, Plus MoreKatie Rowley
MedShadow ArticlesThe Unsettling Truth About Ciprofloxacin: A Wonder Drug’s Darker SideKristel Tjandra, Madeline Reinsel and Gillian Dohrn